| |
| |
|
| Insider
Information: |
Crockett Thomas Andrew |
| Relationship: |
|
| City: |
Salisbury, Wiltshire |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
211,203 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,553,444 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
211,203 |
|
|
| Total
Value |
$2,553,444 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.7
|
| Percentage
Gain/Loss : |
0.0%
|
 160.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kalvista Pharmaceuticals Inc |
KALV |
|
2024-02-20 |
211,203 |
2016-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2024-02-20 |
4 |
S |
$14.11 |
$351,289 |
D/D |
(24,888) |
211,203 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
54,415 |
236,091 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2024-02-14 |
4 |
S |
$15.01 |
$875,883 |
D/D |
(58,356) |
181,676 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2024-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
122,500 |
240,032 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2024-02-01 |
4 |
AS |
$16.18 |
$162,198 |
D/D |
(10,000) |
117,532 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-12-27 |
4 |
AS |
$12.02 |
$360,453 |
D/D |
(30,000) |
127,532 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-11-20 |
4 |
S |
$8.23 |
$121,851 |
D/D |
(14,807) |
157,532 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,583 |
172,339 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-10-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,000 |
138,756 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-08-18 |
4 |
S |
$10.73 |
$159,602 |
D/D |
(14,876) |
146,756 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,582 |
161,632 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-05-18 |
4 |
S |
$10.14 |
$57,083 |
D/D |
(5,627) |
128,050 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,750 |
133,677 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-02-17 |
4 |
S |
$7.66 |
$51,322 |
D/D |
(6,700) |
120,927 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,749 |
127,627 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2022-11-18 |
4 |
S |
$5.44 |
$9,710 |
D/D |
(1,785) |
114,878 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2022-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,805 |
116,663 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2022-09-02 |
4 |
AS |
$17.01 |
$22,458 |
D/D |
(1,320) |
110,858 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2022-08-17 |
4 |
S |
$14.96 |
$26,890 |
D/D |
(1,797) |
112,178 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2022-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,805 |
113,975 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2022-07-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,500 |
112,178 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2022-03-09 |
4 |
AS |
$17.07 |
$170,693 |
D/D |
(10,000) |
114,670 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2021-10-01 |
4 |
AS |
$17.18 |
$171,841 |
D/D |
(10,000) |
124,670 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2021-07-01 |
4 |
AS |
$23.88 |
$241,477 |
D/D |
(10,000) |
134,670 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CEO |
• • – |
2021-06-17 |
4 |
AS |
$30.04 |
$32,051 |
D/D |
(1,067) |
144,670 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
